Virtu Financial LLC Aim Immuno Tech Inc. Transaction History

Virtu Financial LLC

$1.82 Billion
Q3 2024

A detailed history of Virtu Financial LLC transactions in Aim Immuno Tech Inc. stock. As of the latest transaction made, Virtu Financial LLC holds 102,129 shares of AIM stock, worth $23,489. This represents 0.0% of its overall portfolio holdings.

Number of Shares

102,129

Previous 56,200 81.72%

Holding current value

$23,489

Previous $21,000 33.33%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 20, 2024	BUY	$0.24 - $0.42 $11,022 - $19,290	45,929 Added 81.72%	102,129 $28,000
Q2 2024 Aug 09, 2024	BUY	$0.35 - $0.61 $19,670 - $34,282	56,200 New	56,200 $21,000
Q4 2023 Feb 26, 2024	SELL	$0.4 - $0.56 $5,396 - $7,555	-13,492 Reduced 46.43%	15,569 $7,000
Q3 2023 Nov 14, 2023	BUY	$0.44 - $0.71 $12,786 - $20,633	29,061 New	29,061 $13,000
Q4 2022 Feb 15, 2023	SELL	$0.31 - $0.6 $2,458 - $4,758	-7,931 Reduced 19.82%	32,088 $10,000
Q3 2022 Nov 07, 2022	SELL	$0.57 - $0.81 $8,438 - $11,991	-14,804 Reduced 27.0%	40,019 $23,000
Q2 2022 Aug 09, 2022	BUY	$0.78 - $1.27 $3,134 - $5,102	4,018 Added 7.91%	54,823 $43,000
Q1 2022 May 17, 2022	BUY	$0.67 - $1.18 $8,809 - $15,514	13,148 Added 34.92%	50,805 $54,000
Q4 2021 Feb 17, 2022	BUY	$0.92 - $1.96 $34,644 - $73,807	37,657 New	37,657 $35,000
Q2 2021 Sep 17, 2021	SELL	$1.93 - $2.39 $56,904 - $70,466	-29,484 Closed	0 $0
Q1 2021 May 19, 2021	SELL	$1.88 - $2.82 $139,727 - $209,590	-74,323 Reduced 71.6%	29,484 $67,000
Q4 2020 Feb 24, 2021	BUY	$1.68 - $2.45 $124,661 - $181,797	74,203 Added 250.65%	103,807 $186,000
Q3 2020 Dec 11, 2020	SELL	$1.77 - $3.88 $65,417 - $143,400	-36,959 Reduced 55.52%	29,604 $64,000
Q2 2020 Aug 07, 2020	BUY	$1.9 - $2.94 $126,469 - $195,695	66,563 New	66,563 $165,000

Others Institutions Holding AIM

# of Institutions

Shares Held

9.01M

Call Options Held

Put Options Held

View Full List

About AIM ImmunoTech Inc.

Ticker AIM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,049,300
Market Cap $11.1M
Description
AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...

More about AIM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Account

Virtu Financial LLC Aim Immuno Tech Inc. Transaction History